The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrenkel Topping Regulatory News (FEN)

Share Price Information for Frenkel Topping (FEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 53.50
Bid: 53.00
Ask: 54.00
Change: 0.00 (0.00%)
Spread: 1.00 (1.887%)
Open: 53.50
High: 53.50
Low: 53.50
Prev. Close: 53.50
FEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Two Acquisitions

13 Sep 2022 07:00

RNS Number : 1828Z
Frenkel Topping Group PLC
13 September 2022
 

Frenkel Topping Group plc

("Frenkel Topping" or the "Company") 

Acquisitions of Somek and Associates Ltd and N-Able Service Ltd

Continuing the roll-up strategy

Frenkel Topping (AIM: FEN), a specialist professional and financial services firm operating in the Personal Injury and Clinical Negligence space, is pleased to announce the acquisitions of Somek and Associates Ltd ("Somek") and N-Able Service Ltd ("N-Able") (the "Acquisitions").

The Acquisitions are in line with the Board's strategy of expanding the Group's activities in Care & Case management as set out at the time of the Company's July 2022 fundraising. In addition, the acquisition of N-Able adds regional reach in Case Management, helping drive further growth in this sector.

The Acquisitions have been funded through existing cash resources and are within the Company's stated maximum consideration of between c1.25x - 1.5x annual run rate revenue.

The Board expects both Acquisitions to be earnings enhancing in their first full financial year of ownership. Following the Acquisitions, the Company has a net cash position of £6m.

Somek and Associates Ltd

Somek has been operating since 1997 and is one of the largest providers of Expert Witnesses in the UK, delivering highly professional trained experts in a range of health professions. As a trusted source of Expert Witnesses, Somek has a balanced portfolio with equal instructions from claimants and defendants and has experts with specialist experience in all clinical fields based throughout the UK. Somek is a corporate partner of the Expert Witness Institute and was a finalist in the latest Personal Injury Awards Medicolegal provider of the year awards. The addition of Somek to the Company's existing Expert Witness professional service offering transforms the Company into a market leader in this space, particularly in relation to care reports in the personal injury and clinical negligence sector.

Frenkel Topping has agreed to pay an initial cash consideration of £4m (subject to adjustment) with a further cash payment of £1.5m on the first anniversary of completion and an additional earnout of up to £1.5m on the second anniversary of completion subject to certain performance criteria being achieved. Somek recorded revenue of £4.0 million and PAT of £0.6 million for the year to 31 March 2022 and had net assets of £2.0 million as at that date.

N-Able Service Ltd

N-Able is a professional service firm providing Case Management and Care Expert reports focussing on providing specialist, bespoke rehabilitation and lifestyle programmes tailored to the specific needs of its underlying clients. Founded in 2002 in response to the growing demand for bespoke, specialist Case Management services to support those who had experienced catastrophic injuries N-Able Service Ltd is now one of the largest independent Case Management providers in the UK. As a market leader, N-Able Service Ltd works directly with many of the UK's leading law and insurance firms to lead and support clients through the rehabilitation and litigation process and beyond, providing continuing support and rehabilitation, enabling clients to maximise their independence and live life to their fullest.

Frenkel Topping has agreed to pay an initial cash consideration of £0.55m (subject to adjustment) with a further cash payment of £0.275m on the first anniversary of completion and earnout payment of up to £0.275m on the second anniversary of completion subject to certain performance criteria. N-Able had annual run rate revenue of £1m as at 31 May 2022. The Board believes that N-Able's presence in Case Management in regional areas where the Group does not currently operate will bolster the Group's existing Keystone business significantly and provides a platform for growth.

Richard Fraser, Chief Executive Officer of Frenkel Topping, said:

"These are excellent acquisitions and I welcome the businesses and their employees to the Frenkel Topping Group.

The acquisitions reflect the accelerated execution of our M&A growth strategy. With the acquisitions of Somek and N-Able, Frenkel Topping has significantly enhanced its position in the Care and Case Management space, supplementing its Keystone business, which the Company launched in 2021.

As stated at the time of the Company's fundraise earlier this summer, the Board believes Care and Case Management reports to be the largest reports required by solicitors pre-settlement and in addition, case management work post-settlement presents opportunities for repeat revenues. These specific areas are well covered by the addition of N-Able and Somek and should further increase our touchpoints on the journey of a potential claimant, standing the Company in even better stead for unlocking AUM mandates from successful claimants.

In Care management, location is relevant as in-person appointments and associated travel are key to delivering the best service possible. N-Able's location in the North extends our Care and Case management nationally while Keystone, continues to deliver services to our clients in the South."

For further information:  

Frenkel Topping Group plc

www.frenkeltoppinggroup.co.uk

Richard Fraser, Chief Executive Officer

Tel: 0161 886 8000

finnCap Ltd

Tel: 020 7220 0500

Carl Holmes/James Thompson/Milesh Hindocha (Corporate Finance)

Tim Redfern / Charlotte Sutcliffe (ECM)

 

About Frenkel Topping Group: 

The Frenkel Topping Group of companies specialises in providing financial advice and asset protection services to clients at times of financial vulnerability, with particular expertise in the field of personal injury (PI) and clinical negligence (CN).

For more than 30 years the Group has worked with legal professionals and injured clients themselves to provide pre-settlement, at-settlement and post-settlement services to help achieve the best long-term outcomes for clients after injury. It boasts a client retention rate of 99%.

Frenkel Topping Group is focused on consolidating the fragmented PI and CN space in order to provide the most comprehensive suite of services to clients and deliver a best-in-class service offering from immediately after injury or illness and for the rest of their lives.

The group's services include the Major Trauma Signposting Partnership service inside NHS Major Trauma Centres, expert witness, costs, tax and forensic accountancy, independent financial advice, investment management, and care and case management.

The Group's discretionary fund manager, Ascencia, manages financial portfolios for clients in unique circumstances, often who have received a financial settlement after litigation. In recent years Ascencia has diversified its portfolios to include a Sharia-law-compliant portfolio and a number of ESG portfolios in response to increased interest in socially responsible investing (SRI).

Frenkel Topping has earned a reputation for commercial astuteness underpinned by a strong moral obligation to its clients, employees and wider society, with a continued focus on its Environmental, Social and Governance (ESG) impact.

For more information visit: www.frenkeltoppinggroup.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQEAPNAFSKAEFA
Date   Source Headline
23rd Apr 20247:00 amRNSInvestor Presentation via Investor Meet Company
22nd Apr 20247:01 amRNSAcquisition
22nd Apr 20247:00 amRNSFinal Results
12th Mar 20247:00 amRNSNotice of Results
20th Feb 20247:00 amRNSDirectorate Change
24th Jan 20247:00 amRNSTrading Update & New Debt Facility
22nd Dec 20238:00 amRNSHolding(s) in Company
13th Nov 20237:00 amRNSPartnership Programme Grows with New Joint Venture
8th Nov 20234:30 pmRNSDirector/PDMR Shareholding
3rd Nov 20238:30 amRNSHolding(s) in Company
3rd Oct 20237:00 amRNSThe Shares and AJ Bell Media investor event
3rd Oct 20237:00 amRNSAppointment of Strategy & Implementation Director
29th Sep 20237:00 amRNSInterim Results
31st Aug 202310:08 amRNSDirector/PDMR Shareholding
29th Aug 20237:00 amRNSDirector Share Purchase
22nd Aug 20237:00 amRNSTrading Update
31st Jul 20237:00 amRNSFEN Announces Joint Venture with Lime Solicitors
21st Jul 20233:20 pmRNSIssue of consideration shares
6th Jul 20237:00 amRNSFEN announces New Major Trauma Centre
20th Jun 20237:00 amRNSDirector/PDMR Shareholding
14th Jun 202312:20 pmRNSResult of AGM
5th Jun 20237:00 amRNSFEN announces New Major Trauma Centre
15th May 20234:15 pmRNSAnnual Report Posting, Notice of AGM & Dividend
24th Apr 20237:00 amRNSFinal Results
22nd Mar 20234:00 pmRNSHolding(s) in Company
15th Mar 202311:47 amRNSDirector/PDMR Shareholding
8th Mar 20237:00 amRNSInvestor Presentation
13th Feb 20237:00 amRNSFrenkel Topping Partnership Programme Grows
7th Feb 20237:00 amRNSTrading Update and Notice of Results
10th Nov 20222:50 pmRNSInterim Dividend Timetable
3rd Nov 20227:00 amRNSFEN to present at AJ Bell investor webinar
24th Oct 20222:30 pmRNSDirector/PDMR Shareholding and Holdings in Company
24th Oct 202212:15 pmRNSHolding(s) in Company
3rd Oct 20227:00 amRNSDirector/PDMR Shareholding
26th Sep 20227:00 amRNSInterim Results
13th Sep 20227:00 amRNSCompletion of Two Acquisitions
31st Aug 20222:15 pmRNSNotice of Results
3rd Aug 202210:17 amRNSHolding(s) in Company
3rd Aug 202210:15 amRNSHolding(s) in Company
29th Jul 202212:15 pmRNSResult of General Meeting
25th Jul 20227:00 amRNSFEN Announces Joint Venture with CFG Law
25th Jul 20227:00 amRNSFEN Announces Joint Venture with CFG Law
12th Jul 202210:50 amRNSHolding(s) in Company
6th Jul 20227:00 amRNSResults of Placing
5th Jul 20222:45 pmRNSProposed Placing to raise approximately £10m
22nd Jun 202211:40 amRNSResult of AGM
16th May 20228:25 amRNSAnnual Report Posting, Notice of AGM & Dividend
4th May 20221:00 pmRNSDirector/PDMR Shareholding
25th Apr 20227:00 amRNSFinal Results
15th Feb 20227:00 amRNSTrading Update and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.